It elevates cortisol, promotes insulin resistance, and impairs decision-making around food
Due to their cost, however, coverage of GLP-1s for obesity treatment in Medicaid, ACA Marketplace plans, and most large employer firms remains limited, and GLP-1 coverage in Medicare for treatment of obesity is prohibited under current law
"We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." GoodRx replaces a now-defunct partnership between Novo Nordisk and Hims & Hers, which broke down due to what the drugmaker said were concerns about "illegal mass compounding and deceptive marketing." In a statement, GoodRx chief executive Wendy Barnes said that demand for GLP-1 drugs "is at an all-time high, but too many Americans still face barriers accessing them
GLP-1 weight loss injections have gained tremendous popularity in recent years, with medications like Wegovy , Ozempic , and Saxenda leading the way in medically supervised weight management